Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2024 Filed Apr 2, 2024 16:49 UTC
DALY RICHARD JDirector · Executive Chairman
Tax withholdingCommon Stock 438 $203.23 $89,014.74
Disclosure

SEC source: 0001225208-24-004803 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,282.9949

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:50 UTC
Stingi Richard JohnCorporate VP and CHRO
Tax withholdingCommon Stock 928 $203.23 $188,597.44
Disclosure

SEC source: 0001225208-24-004806 · doc4.xml · nonDerivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,069.799

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:49 UTC
KALENKA ROBERT FCorporate Vice President
Tax withholdingCommon Stock 692 $203.23 $140,635.16
Disclosure

SEC source: 0001225208-24-004804 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,867.4097

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:49 UTC Tax withholdingCommon Stock 703 $203.23 $142,870.69
Disclosure

SEC source: 0001225208-24-004802 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,776.8948

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:49 UTC
Reese EdmundCorporate VP and CFO
Tax withholdingCommon Stock 2,896 $203.23 $588,554.08
Disclosure

SEC source: 0001225208-24-004801 · doc4.xml · nonDerivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,491.46

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:49 UTC Tax withholdingCommon Stock 3,362 $203.23 $683,259.26
Disclosure

SEC source: 0001225208-24-004800 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,288.521

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:01 UTC
keller brettDirector
GrantCommon Stock 142 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004571 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,059

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:02 UTC GrantCommon Stock 142 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004573 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,024

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:02 UTC
Zavery AmitDirector
GrantCommon Stock 130 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004575 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,455

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:02 UTC GrantCommon Stock 142 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004574 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,489

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:01 UTC GrantCommon Stock 161 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004572 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,670.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 19:27 UTC SaleCommon Stock 12,200 $204.71 $2,497,474.20
Disclosure

SEC source: 0001225208-24-003837 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,479.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.6106 - $204.9600, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 22:18 UTC SaleCommon Stock 830 $201.58 $167,311.40
Disclosure

SEC source: 0001225208-24-003483 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · BOMAR II LLC

Disclosed balance after: 5,445

Read SEC document
February 28, 2024 Filed Feb 28, 2024 18:20 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 14,712 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-24-003187 · doc4.xml · derivative · entry 3

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,712 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 18:20 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 12,731 $201.02 $2,559,130.88
Disclosure

SEC source: 0001225208-24-003187 · doc4.xml · nonDerivative · entry 2

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,303

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 - $201.58, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 18:20 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 14,712 $98.31 $1,446,336.72
Disclosure

SEC source: 0001225208-24-003187 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,034

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 15, 2024 18:36 UTC
KALENKA ROBERT FCorporate Vice President
GiftCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002108 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,559.4097

F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 13:03 UTC
Matlin LauraCVP, Deputy GC and CCO
GrantStock Option (Right to Buy) · Derivative 1,895 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002273 · doc4.xml · derivative · entry 1

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,895

Underlying: Common Stock · 1,895 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC GrantStock Option (Right to Buy) · Derivative 106,920 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002271 · doc4.xml · derivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,920

Underlying: Common Stock · 106,920 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 13:03 UTC
DALY RICHARD JDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 5,086 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002269 · doc4.xml · derivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,086

Underlying: Common Stock · 5,086 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:04 UTC
Stingi Richard JohnCorporate VP and CHRO
GrantStock Option (Right to Buy) · Derivative 6,981 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002276 · doc4.xml · derivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,981

Underlying: Common Stock · 6,981 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC
Reese EdmundCorporate VP and CFO
GrantStock Option (Right to Buy) · Derivative 25,932 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002275 · doc4.xml · derivative · entry 1

Reese Edmund · CIK 0001833903 · Corporate VP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,932

Underlying: Common Stock · 25,932 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC GrantStock Option (Right to Buy) · Derivative 29,921 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002274 · doc4.xml · derivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,921

Underlying: Common Stock · 29,921 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC
KALENKA ROBERT FCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 4,438 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002272 · doc4.xml · derivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,438

Underlying: Common Stock · 4,438 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC GrantStock Option (Right to Buy) · Derivative 5,735 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002270 · doc4.xml · derivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,735

Underlying: Common Stock · 5,735 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 18:03 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 16,955 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-24-002268 · doc4.xml · derivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,955

Underlying: Common Stock · 16,955 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 15:44 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 27,778 $50.95 Strike: $50.95 $1,415,289.10
Disclosure

SEC source: 0001225208-24-001716 · doc4.xml · derivative · entry 3

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,778 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 15:44 UTC SaleCommon Stock 22,722 $199.00 $4,521,684.82
Disclosure

SEC source: 0001225208-24-001716 · doc4.xml · nonDerivative · entry 2

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,679.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.0000 - $199.0600, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 15:44 UTC Exercise / conversionCommon Stock 27,778 $50.95 $1,415,289.10
Disclosure

SEC source: 0001225208-24-001716 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,401.8948

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 79 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000601 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,646

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000602 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,682

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC
keller brettDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000603 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,917

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC
keller brettDirector
GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000603 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,905

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 12:27 UTC GrantCommon Stock 113 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000599 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,392

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000605 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,882

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 4 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000605 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,880

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC
Zavery AmitDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000607 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,325

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC
Zavery AmitDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000607 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,313

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000606 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,347

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000606 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,341

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000604 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,509.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 53 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000604 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,495.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 17:27 UTC GrantCommon Stock 18 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-000600 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,613

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
December 28, 2023 Filed Dec 28, 2023 18:52 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,438 $148.07 Strike: $148.07 $805,204.66
Disclosure

SEC source: 0001225208-23-011357 · doc4.xml · derivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,438

Underlying: Common Stock · 5,438 shares

Expires 2031-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 28, 2023 Filed Dec 28, 2023 18:52 UTC SaleCommon Stock 5,069 $205.32 $1,040,752.38
Disclosure

SEC source: 0001225208-23-011357 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,650.521

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.0000 - $205.3171, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
December 28, 2023 Filed Dec 28, 2023 18:52 UTC Exercise / conversionCommon Stock 5,438 $148.07 $805,204.66
Disclosure

SEC source: 0001225208-23-011357 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,719.521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 26, 2023 Filed Dec 26, 2023 17:35 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,094 $148.07 Strike: $148.07 $1,050,408.58
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · derivative · entry 6

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,876

Underlying: Common Stock · 7,094 shares

Expires 2031-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 26, 2023 Filed Dec 26, 2023 17:35 UTC SaleCommon Stock 6,643 $200.17 $1,329,702.07
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 4

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,281.521

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.0000 - $200.2900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
December 26, 2023 Filed Dec 26, 2023 17:35 UTC Exercise / conversionCommon Stock 7,094 $148.07 $1,050,408.58
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,924.521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 17:35 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,906 $148.07 Strike: $148.07 $430,291.42
Disclosure

SEC source: 0001225208-23-011328 · doc4.xml · derivative · entry 5

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,970

Underlying: Common Stock · 2,906 shares

Expires 2031-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.